Asia Pacific: In Asia Pacific, China is the largest consumer of chondroitin, followed by Japan and South Korea. The increasing awareness about the health benefits of chondroitin among consumers in these countries is driving the market growth. The rise in disposable income levels and changing lifestyle habits are also fueling the demand for chondroitin in the region.
Europe: The chondroitin market in Europe is led by countries like the United Kingdom, Germany, and France. The market growth in these countries is mainly attributed to the rising prevalence of joint-related diseases and the increasing adoption of chondroitin supplements as a preventive measure. The presence of key market players and growing investments in research and development activities are also contributing to the market expansion in Europe.